# Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

> **NCT04599478** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Yale University** · enrollment: 160 (estimated)

## Conditions studied

- Loss-of-control Eating
- Obesity/Overweight

## Interventions

- **DRUG:** Naltrexone and Bupropion medication
- **BEHAVIORAL:** Behavioral Weight Loss
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04599478
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-29
- **Primary completion:** 2025-12-12
- **Final completion:** 2027-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04599478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04599478, "Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04599478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*